The latest report by IMARC Group, titled" Synthetic Biology Market Report by Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-nucleic Acids, Chassis Organism), Technology (NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, and Others), Application (Healthcare, Non-Healthcare), and Region 2024-2032", offers a comprehensive analysis of the industry, which comprises insights on the market. The global synthetic biology market size reached US$ 16.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 62.0 Billion by 2032, exhibiting a growth rate (CAGR) of 15.9% during 2024-2032.

 

Factors Affecting the Growth of the Synthetic Biology Industry:

  • Technological Advancements in Synthetic Biology:

Technological progress in synthetic biology, particularly in gene editing tools like CRISPR-Cas9, has significantly enhanced the capabilities and speed of genetic engineering. CRISPR-Cas9 allows for precise modifications to DNA at specific locations, enabling researchers to alter genetic sequences more efficiently and with greater accuracy than ever before. Additionally, advancements in DNA synthesis technology have streamlined the process of constructing DNA sequences from scratch, further accelerating research and development in this field. Moreover, automation techniques in laboratory processes have also improved, increasing throughput and reducing the potential for human error. These technological advancements quicken the pace of discovery and innovation in synthetic biology and expand the potential applications of this field, ranging from medicine to agriculture, by allowing for more complex and refined genetic modifications.



  • Biomaterials Innovation:

Several advances in biomaterials are essential for the expansion of synthetic biology applications across various sectors. Additionally, engineered organisms are now being developed to produce bio-based chemicals and biofuels, offering a more sustainable alternative to traditional petrochemicals. These organisms can be tailored to convert raw materials like sugars or agricultural waste into valuable products, including plastics, fibers, and fuels, through designed metabolic pathways. The innovation extends to the development of new biomaterials that are biodegradable and have enhanced functionality compared to their synthetic counterparts. As a result, industries ranging from pharmaceuticals to textiles are turning to bio-engineered solutions to improve product performance and environmental footprint. The continuous improvement in biomaterials technology is thus enhancing the efficiency of bioproduction while driving broader adoption of these sustainable practices across the globe.



  • Growing Environmental Concerns:

The increasing awareness of environmental issues such as climate change, pollution, and resource depletion has increased the demand for sustainable solutions, where synthetic biology offers significant potential. Additionally, synthetic biology can help reduce greenhouse gas (GHG) emissions, promote energy efficiency, and minimize waste by leveraging engineered organisms and bioprocesses. For example, the development of bio-based alternatives to fossil fuels can decrease dependency on non-renewable resources and mitigate the impact of energy production on the environment. Moreover, synthetic biology can contribute to carbon sequestration efforts, where engineered plants or microbes capture and store atmospheric CO2 more effectively. The field’s ability to address environmental challenges makes it crucial to the pursuit of sustainability and aligns it with global efforts to combat ecological degradation and promote a more sustainable future.

 

For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/synthetic-biology-market/requestsample

 

Leading Companies Operating in the Global Synthetic Biology Market

  • Agilent Technologies Inc.
  • Amyris Inc.
  • Codexis Inc.
  • Danaher Corporation
  • Eurofins Scientific
  • GenScript Biotech Corporation
  • Illumina Inc.
  • Merck KGaA
  • New England Biolabs
  • Synthego Corporation
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience
  • Viridos Inc.

 

Synthetic Biology Market Report Segmentation: 

 

By Product: 

  • Oligonucleotide/Oligo Pools and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Xeno-nucleic Acids
  • Chassis Organism

Oligonucleotide/oligo pools and synthetic DNA represent the largest segment due to their critical role in numerous applications, including gene synthesis, CRISPR gene editing, and diagnostic assays, driving their extensive demand across research and commercial sectors.

 

By Technology: 

  • NGS Technology
  • PCR Technology
  • Genome Editing Technology
  • Bioprocessing Technology
  • Others

Based on technology, the market has been categorized into NGS, PCR, genome editing, bioprocessing, and other technologies

 

By Application: 

·         Healthcare

o    Clinical

o    Non-Clinical/Research

·         Non-Healthcare

o    Biotech Crops

o    Specialty Chemicals

o    Bio-Fuels

o    Others

On the basis of application, the market has been classified into healthcare (clinical and non-clinical/research) and non-healthcare (biotech crops, specialty chemicals, bio-fuels, and others).

 

Regional Insight:

 

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

 

North America’s dominance in the synthetic biology market is attributed to robust biotechnology research infrastructure, substantial investments in biotech and pharmaceutical sectors, and strong governmental and academic support for advancing synthetic biology technologies.

Global Synthetic Biology Market Trends:

At present, synthetic biology is enabling the development of bio-based manufacturing processes to produce chemicals, materials, and pharmaceuticals. This shift toward sustainable and environmentally friendly manufacturing practices is driving the adoption of synthetic biology solutions. Moreover, the market has been experiencing rapid growth driven by advancements in gene editing technologies, automation, and the decreasing cost of DNA synthesis. This growth is expected to continue as more applications are discovered and developed. Furthermore, synthetic biology is finding applications across several industries including healthcare, agriculture, energy, chemicals, and materials, thus expanding the market potential and attracting interest from various sectors.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

 

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

 

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

 

IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.

 

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

 

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145